A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its ...

DexCom DXCM is facing regulatory scrutiny following a warning letter recently posted by the FDA. This could affect the ...

Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

DexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024.The FDA cited deficiencies in the company’s manufacturing ...

Here the authors demonstrate magnetic gradients which enable nanoscale imaging by developing a nanowire on a tip and incorporating it with an atomic sensor, that can then be used to map electrons ...

Interventions Participants were randomly assigned to Dexcom G6 CGM (n=30) use or usual care (UC ... Results Participants tolerated CGM well but were unable to change their own sensors which resulted ...

The updated G6 is a model developed for the global markets and will be offered in left- and right-hand drive versions. The new G6 will be officially launched in early March, when pricing will be ...

On the 2025 G6, 34 percent of the tier 1 assembly parts have been replaced and 81 experiences have been upgraded, said Xpeng CEO. The G6's regulatory filing makes no mention of LiDAR, signaling that ...

Continuous glucose monitoring systems consist of an interstitial glucose sensor, a transmitter, and a receiver that together ... have been used in neonates: Dexcom (SanDiego, CA, USA) and Medtronic ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...